Excellent. **STEP 9** is where we convert validated results into a **coherent, reviewer-resilient manuscript blueprint** tailored specifically to *Nature Machine Intelligence*. The goal is not prose yet, but a **claim–evidence–figure–method alignment** that makes the paper easy to accept and hard to misunderstand.

Nothing speculative is introduced here; every claim maps to artifacts you already generated in Steps 7–8.

---

# **STEP 9 — Paper-Ready Outline (Nature Machine Intelligence)**

## **9.1 Target Journal Constraints (Implicitly Enforced)**

This outline is designed to satisfy *Nature Machine Intelligence* expectations:

* **Conceptual ML novelty** (not just application)
* **Strong grounding in a scientific domain**
* **Clear separation of method vs results**
* **Ensemble-level reasoning**
* **Minimal but powerful figures**

We will explicitly avoid:

* benchmark dumping
* architectural clutter
* “yet another diffusion model” framing

---

## **9.2 Title (Working, High-Probability)**

> **A machine-learning surrogate for cryptic pocket formation and activation dynamics in proteins**

Key properties:

* “surrogate” is the central claim
* unifies cryptic pockets and GPCR activation
* no buzzwords, no overreach

Subtitle (optional later):

> *Learning side-chain mobility fields to approximate long-timescale molecular dynamics*

---

## **9.3 Abstract (Structured, Not Written Yet)**

The abstract will follow this logic:

1. **Problem**
   Long-timescale MD reveals cryptic pockets and activation pathways but is computationally prohibitive.

2. **Gap**
   Existing ML methods predict static structures or binding poses, not **dynamical accessibility**.

3. **Contribution**
   Introduce a **machine-learning surrogate** that approximates MD-derived ensembles using a learned side-chain mobility field.

4. **Validation**
   Quantitative agreement with Anton trajectories and fragment-bound structures.

5. **Impact**
   Enables rapid exploration of cryptic binding and activation landscapes without long MD.

Every sentence will map to a section below.

---

## **9.4 Main Text Structure**

### **1. Introduction**

**Goal:** Frame the problem so your solution feels inevitable.

#### 1.1 Cryptic pockets and activation are dynamical phenomena

* Static structures miss functional states
* Long MD (Anton) reveals them but is inaccessible

#### 1.2 Limits of existing ML approaches

* Pocket detectors: geometry only
* Docking models: binding without dynamics
* Structure predictors: single states, not ensembles

#### 1.3 Surrogate modeling as the missing paradigm

* Define “surrogate” explicitly
* Position your approach as *approximating MD outputs, not replacing physics*

**End with a clear statement of contributions (bullet list).**

---

### **2. Overview of the Surrogate Architecture**

**Figure 1 goes here.**

This is a *conceptual* section, light on math.

#### 2.1 Causal decomposition of dynamics

Structure → side-chain entropy → pocket formation / activation

#### 2.2 Side-Chain Mobility Field (SCMF)

* What it represents physically
* Why side chains matter for cryptic pockets

#### 2.3 Conditional diffusion as ensemble generator

* Why diffusion
* Why conditioning on SCMF
* Why one model can handle structure *and* scalar dynamics

This section must be readable by non-specialists.

---

### **3. Methods**

This section is technical but clean. No results.

#### 3.1 Systems and datasets

* PTP1B (cryptic fragment system)
* A2A adenosine receptor (activation system)
* Anton trajectories as ground truth

#### 3.2 SCMF target definition

* χ-angle transitions
* MD-derived labels
* Physical interpretation

#### 3.3 SCMF model architecture

* residue graph
* inputs / outputs
* loss

#### 3.4 Conditional diffusion model

* conditioning mechanism
* dual usage (poses vs activation scalar)
* training objective

#### 3.5 Evaluation metrics

* TM6 displacement
* pocket overlap
* fragment RMSD
* distributional metrics

Everything here is already implemented.

---

### **4. Results — GPCR Activation Surrogate**

**Figure 2 + Table 1**

#### 4.1 Surrogate reproduces Anton activation order parameter

* Correlation
* RMSE

#### 4.2 Ensemble fidelity

* Distribution overlays
* KS / KL metrics

#### 4.3 Role of side-chain mobility conditioning

* Ablation without SCMF
* Explicit degradation

This section sells the *dynamical* claim.

---

### **5. Results — Cryptic Pocket Formation in PTP1B**

**Figure 3 + Table 2**

#### 5.1 Cryptic pocket localization

* Pocket overlap vs baselines

#### 5.2 Fragment pose accuracy

* RMSD comparisons

#### 5.3 Side-chain realism

* χ-angle agreement
* Why this matters mechanistically

This section sells the *structural* claim.

---

### **6. Discussion**

This is where your background shines.

#### 6.1 SCMF as a learned entropy proxy

* Relation to NMR ensembles
* Relation to rotamer entropy

#### 6.2 What the surrogate captures — and what it does not

* No explicit kinetics
* No full free-energy surfaces
* Still valuable

#### 6.3 Implications for drug discovery

* Cryptic pockets
* GPCR allostery
* Screening without long MD

#### 6.4 Future directions

* More systems
* Explicit kinetics
* Hybrid physics–ML loops

---

### **7. Conclusion**

Short, restrained, confident.

> We demonstrate that learned side-chain mobility fields can be used to construct a machine-learning surrogate that approximates long-timescale molecular dynamics, enabling efficient exploration of cryptic binding and activation landscapes.

No hype.

---

## **9.5 Figures & Tables (Final Allocation)**

### **Main Figures**

1. Architecture schematic
2. A2A activation ensemble comparison
3. PTP1B cryptic pocket & fragment results

### **Main Tables**

1. A2A activation metrics
2. PTP1B comparison & ablations

### **Supplementary**

* Additional ablations
* Runtime comparisons
* Extra trajectory plots

---

## **9.6 Claim–Evidence Map (Reviewer Armor)**

| Claim                     | Evidence                          |
| ------------------------- | --------------------------------- |
| Surrogate approximates MD | Anton correlations, distributions |
| SCMF is necessary         | Ablation tables                   |
| Works across domains      | GPCR + enzyme                     |
| Not a docking model       | χ-angle realism                   |
| Efficient                 | Runtime metrics                   |

No claim is unsupported.

---

## **Checkpoint Summary**

At the end of **Step 9**, you have:

* a full NMI-aligned outline
* figure placement locked
* claims mapped to data
* a clear narrative arc
* zero structural risk

This is a **publishable plan**, not a draft.

---

## **Final Step**

### **STEP 10 — Writing the Manuscript**

This will involve:

* section-by-section drafting
* precise, restrained language
* iterative tightening
* reviewer anticipation

When you are ready, say:

> **“Proceed to Step 10.”**

From here, we write.
